Schedule IV [21 CFR 1308.14]
Source: Shulgin, Alexander T. Controlled Substances: Chemical & Legal Guide to Federal Drugs Laws (2nd edition). Ronin Publishing Inc., Berkeley, 1992
Source: DEA Office of Diversion Control: Section 1308: Schedules of Controlled Substances
Effective 15 May 2003, 68 FR 26247 withdrew the prior proposed rule.
On 6 May 1997, 62 FR 24620 proposed to revoke:
Effective 15 Jun 1973, 38 FR 15719 added:
(d)
Fenfluramine. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:
Effective 15 Jun 1973, 38 FR 15719 added:
On 9 May 1973, 38 FR 12123 proposed to add:
(1)
1670
Fenfluramine
Effective 7 Jun 2013, 78 FR 26701 added (and renumbered subsequent entries):
On 19 Dec 2012, 77 FR 75075 proposed to add (and to renumber subsequent entries):
(e)
Lorcaserin. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:
Effective 7 Jun 2013, 78 FR 26701 added:
On 19 Dec 2012, 77 FR 75075 proposed to add:
(1)
1625
Lorcaserin
⇒
PubChem: 11658860; ChemSpider: 9833595; Bluelight: Lorcaserin; Erowid: Lorcaserin; Wikipedia: Lorcaserin(f)
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:
Effective 31 Dec 1969, replacement for:
Effective 6 Jul 1973, 38 FR 18013 added:
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of isomers whenever the existance of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
Effective 6 Jul 1973, 38 FR 18013 added:
(2)
1610
Diethylpropion
CA: CDSA Schedule IV Section 4 Diethylpropion
UK: MDA Part II Class B Section 1(aa) Diethylpropion and Part III Class C Section 1(a) Diethylpropion
UN: Psychotropics Schedule IV Amfepramone (Diethylpropion)
Effective 16 Jun 1988, 53 FR 17459 added (and renumbered subsequent entries):
(3)
1760
Fencamfamin
CA: CDSA Schedule IV Section 20 Fencamfamin
UK: MDA Part III Class C Section 1(a) Fencamfamin
UN: Psychotropics Schedule IV Fencamfamin
Effective 16 Jun 1988, 53 FR 17459 added (and renumbered subsequent entries):
(4)
1575
Fenproporex
CA: CDSA Schedule IV Section 21 Fenproporex
UK: MDA Part III Class C Section 1(a) Fenproporex
UN: Psychotropics Schedule IV Fenproporex
Effective 28 Jan 1975, 40 FR 4150 added:
On 7 Nov 1974, 39 FR 39451 proposed to add:
(8)
1530
Pemoline (including organometallic complexes and chelates thereof)
Effective 6 Jul 1973, 38 FR 18013 added:
(9)
1640
Phentermine
CA: CDSA Schedule IV Section 8 Phentermine
UK: MDA Part III Class C Section 1(a) Phentermine
UN: Psychotropics Schedule IV Phentermine
Effective 11 Feb 1998, 63 FR 6862 added:
On 8 Dec 1997, 62 FR 64526 proposed to add:
(11)
1675
Sibutramine
⇒
PubChem: 5210; ChemSpider: 5021; Bluelight: Sibutramine (amphetamines); Drugs Forum: Sibutramine addiction; Wikipedia: Sibutramine
Effective 1 Dec 1980, 45 FR 64570 added:
(12)
1635
SPA ((–)-1-Dimethylamino-1,2-diphenylethane)
CA: CDSA Schedule III Section 29 Lefetamine
UK: MDA Part II Class B Section 1(a) Lefetamine
UN: Psychotropics Schedule IV Lefetamine (SPA)
⇒
PubChem: 22779; ChemSpider: 21356; Bluelight: Lefetamine; Drugs Forum: Lefetamine; Wikipedia: Lefetamine11 March 2016 · 
· Isomer Design
· Isomer Design